Achmea Investment Management B.V. 10x Genomics, Inc. Transaction History

Achmea Investment Management B.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$36.95 - $82.41 $5,875 - $13,103	-159 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $227,980 - $596,718	-4,093 Reduced 96.26%	159 $12,000
Q3 2021 Nov 12, 2021	BUY	$145.58 - $192.14 $23,147 - $30,550	159 Added 3.88%	4,252 $619,000
Q1 2021 May 11, 2021	BUY	$140.25 - $196.86 $574,043 - $805,747	4,093 New	4,093 $740,000

319

118M

330K

157K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.23B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

Stay updated on Achmea Investment Management B.V. with notifications on news.